About FDA

Office of Surveillance and Epidemiology (OSE) - Programs and Activities

Office of Surveillance and Epidemiology (OSE) Home

  • Approved Risk Evaluation and Mitigation Strategies (REMS)

  • Drug Safety and Risk Management (DSaRM) Advisory Committee gained full committee status on June 1, 2002.
  • MedWatch  MedWatch, the FDA Safety Information and Adverse Event Reporting Program, provides safety information for all FDA-regulated medical products (drugs, biologics, medical devices, and dietary supplements) to both healthcare professionals and the general public. 
    • MedWatch Partners work with FDA to help keep their members informed about medical product safety information


Page Last Updated: 02/12/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English